agent
cdc
us
depart
agricultur
develop
countermeasur
rvfv
import
minim
impact
rvf
exampl
earli
detect
rvfv
diagnosi
rvf
minim
time
govern
take
action
prevent
spread
rvfv
although
postmortem
examin
includ
immunohistochemistri
still
use
identifi
rvfv
rapid
detect
viral
rna
virem
sampl
done
convent
realtim
rtpcr
loopmedi
isotherm
amplif
lamp
recombinas
polymeras
amplif
assay
rpa
altern
antigencaptur
sandwich
elisa
use
detect
rvfv
antigen
situat
viral
rna
stabli
preserv
field
sinc
virem
period
short
use
wholeblood
sampl
rather
sera
could
increas
sensit
rvfv
rna
detect
identif
anim
human
igm
specif
rvfv
igmcaptur
elisa
also
import
sinc
recent
infect
statu
ie
within
month
indic
histori
rvfv
spread
area
detect
rvfv
igm
specif
rvfv
rapid
contain
rvfv
requir
addit
cull
infect
anim
vaccin
may
effect
way
prevent
anim
amplifi
rvfv
area
endem
countri
liveattenu
smithburn
vaccin
use
sinc
deriv
mous
brainadapt
entebb
strain
use
smithburn
vaccin
pregnant
anim
prohibit
risk
abort
vaccin
approv
veterinari
purpos
endem
countri
usa
liveattenu
vaccin
develop
egyptian
strain
serial
plaqu
purif
presenc
chemic
mutagen
manufactur
salk
institut
vaccin
approv
condit
emerg
vaccin
veterinari
use
term
vaccin
also
test
human
phase
ii
clinic
trial
signific
advers
effect
report
although
highli
efficaci
suffici
safe
lack
marker
differenti
infect
vaccin
anim
diva
might
compromis
monitor
anim
upon
introduct
rvfv
addit
liveattenu
vaccin
may
best
choic
human
term
safeti
usa
highli
safe
formalininactiv
vaccin
rvf
avail
howev
dose
limit
less
immunogen
compar
ideal
vaccin
rvf
might
one
encompass
high
efficaci
rapidli
induc
protect
immun
rumin
human
perfect
safeti
particular
human
diva
marker
veterinari
purpos
lowcost
manufactur
transmiss
mosquito
vector
although
rvfv
still
larg
contain
africa
develop
better
vaccin
rvf
import
task
usa
countri
rvfv
tripartit
negativestrand
rna
genom
name
small
medium
larg
l
segment
figur
phlebovirus
ssegment
nt
encod
nucleocapsid
n
gene
negativesens
viralsens
genom
nonstructur
nss
gene
positivesens
antiviralsens
genom
ambisens
manner
n
protein
encapsid
viral
genom
rna
requir
viral
rna
synthesi
packag
viral
rna
virion
nss
protein
major
virul
factor
rvfv
although
dispens
viral
replic
msegment
nt
encod
singl
open
read
frame
orf
mrna
make
least
four
differ
protein
ie
nsm
gn
gc
leaki
scan
five
differ
initi
codon
well
cotransl
cleavag
polypeptid
gn
gc
viral
envelop
protein
form
heterodim
surfac
virion
form
capsom
consid
gn
play
role
receptor
bind
gc
serv
class
ii
fusion
protein
nsm
protein
also
describ
dispens
rvfv
replic
local
outer
membran
mitochondria
delay
progress
apoptosi
infect
cell
protein
also
describ
less
character
yet
incorpor
virion
suggest
lsegment
nt
encod
singl
orf
rnadepend
rna
polymeras
l
protein
l
protein
play
role
genom
rna
replic
viral
mrna
transcript
l
protein
snatch
host
mrna
use
primer
transcript
cap
snatch
thu
viral
mrna
contain
heterogen
sequenc
nterminu
review
lihoradova
ikegami
futur
scienc
group
l
protein
encod
domain
conserv
bunyavirus
arenavirus
may
serv
endonucleas
cleav
host
mrna
capsnatch
process
viral
attach
occur
gngc
dcsign
altern
viru
bind
heparansulf
entri
upon
attach
viral
receptor
rvfv
enter
cell
dynamindepend
caveolaemedi
endocytosi
like
phlebovirus
rvfv
may
also
caus
membran
fusion
cell
late
endosom
via
exposur
gc
fusion
loop
sinc
viral
l
protein
attach
viral
ribonucleocapsid
rnp
viral
genom
rna
encapsid
n
protein
virion
incom
genom
rna
immedi
becom
templat
mrna
synthesi
theoret
n
mrna
mrna
l
mrna
transcrib
negativestrand
mand
lsegment
respect
primari
transcript
nss
mrna
transcrib
positivestrand
ssegment
viral
genom
rna
replic
howev
nss
mrna
also
found
transcrib
primari
transcript
stage
found
negativesens
positivesens
mand
lsegment
packag
virion
allow
headstart
synthesi
nss
mrna
infect
cell
subsequ
viral
rna
genom
replic
occur
accumul
viral
mrna
also
occur
secondari
transcript
viral
assembl
process
start
golgi
region
gn
encod
golgi
retent
signal
transmembran
domain
cytoplasm
domain
gc
encod
er
retent
signal
coexpress
gn
gc
allow
accumul
gngc
golgi
region
sinc
matrix
protein
cytoplasm
domain
gngc
consid
viral
compon
interact
rnp
although
littl
research
regard
far
gn
gc
encod
one
four
nglycosyl
site
respect
may
play
role
matur
viral
virion
well
attach
dcsign
receptor
next
infect
cycl
rvfv
caus
uniqu
patholog
differ
anim
speci
suscept
host
speci
follow
mousehamsterlamb
ratsheep
humanmonkeycowgoat
symptomat
diseas
occur
rabbit
pig
hors
guinea
pig
bird
mous
one
suscept
anim
speci
rvfv
die
day
postinfect
either
fulmin
hepat
viral
spread
cn
upon
entri
rvfv
mous
dendrit
cell
macrophag
granulocyt
may
primari
target
cell
balbc
mice
infect
rvfv
strain
pfu
subcutan
viru
spread
systemat
day
postinfect
dpi
eg
liver
spleen
kidney
heart
adren
gland
viral
antigen
effici
clear
tissu
dpi
time
rvfv
spread
throughout
cn
around
dpi
lead
death
mice
control
virul
rvf
import
know
clearanc
rvfv
occur
report
passiv
transfer
neutral
antibodi
suffici
protect
hamster
virul
rvfv
challeng
result
indic
neutral
antibodi
suffici
protect
host
progress
diseas
viral
evas
host
occur
nss
protein
sinc
rvfv
lack
nss
induc
abund
typei
interferon
ifn
mice
establish
viremia
hand
mice
lack
ifnar
succumb
infect
rvfv
lack
nss
indic
host
innat
immun
play
import
role
prevent
rvfv
replic
viral
replic
induc
death
mice
even
without
nss
host
compet
innat
immun
system
use
mous
model
requir
mice
protect
diseas
due
rvfv
lack
nss
studi
although
bcelldefici
mice
larg
resist
infect
mice
dead
challeng
wildtyp
rvfv
hand
mice
deplet
cell
deplet
cell
succumb
lethal
enceph
caus
infect
therefor
cell
mayb
neutral
antibodi
cell
play
import
role
viral
clearanc
prevent
progress
diseas
model
result
also
consist
find
mice
neutral
antibodi
alway
protect
wildtyp
rvfv
challeng
studi
indic
cellular
immun
respons
toward
n
protein
also
alter
patholog
diseas
current
remain
unknown
viral
clearanc
occur
immun
cell
liver
organ
describ
rvfv
nss
play
role
evas
host
innat
immun
nss
protein
amino
acid
form
uniqu
filament
structur
nucleu
although
also
accumul
cytoplasm
figur
ctermin
amino
acid
requir
format
nss
filament
typic
nuclear
local
signal
nss
four
prolinerich
motif
pxxp
motif
two
phosphoryl
site
casein
kinas
ii
ser
ser
mutat
pxxp
motif
could
larg
abolish
accumul
filament
format
nss
nucleu
mutat
ser
affect
review
lihoradova
ikegami
futur
scienc
group
filament
format
nss
respons
suppress
gene
express
intact
pxxp
motif
appear
import
nss
function
inhibit
gene
occur
transcript
level
inhibit
mrna
synthesi
occur
presenc
activ
three
import
transcript
factor
promot
activ
infect
cell
subsequ
found
rvfv
nss
could
bind
sequest
subunit
protein
tfiih
essenti
transcript
factor
host
rna
polymeras
ii
inhibit
gener
host
transcript
rvfv
nss
also
bind
propos
recruit
interrupt
nss
filament
bound
gene
promot
via
still
unclear
two
distinct
mechan
affect
promot
suppress
sinc
avail
mutant
lack
either
function
rvfv
nss
also
promot
posttransl
degrad
dsrnadepend
pkr
degrad
pkr
requir
replic
rvfv
pkr
could
stabil
presenc
proteasom
inhibitor
point
mutat
alanin
could
abolish
pkr
degrad
function
due
lack
specif
interact
pkr
interestingli
mutant
nss
could
form
filament
structur
mosaiclik
pattern
nucleu
distinct
intact
nss
filament
allow
earli
accumul
phosphoryl
infect
cell
dramat
decreas
accumul
viral
protein
find
indic
rvfv
regul
host
transcript
suppress
pkr
degrad
independ
although
mechan
earli
accumul
phosphoryl
remain
unclear
similar
phenomenon
also
observ
cell
infect
rvfv
lack
nss
presenc
transcript
inhibitor
actinomycin
thu
propos
nssmediat
pkr
degrad
play
import
role
activ
viral
translat
presenc
host
transcript
suppress
induc
nss
tfiih
consist
ten
subunit
protein
xpd
gene
defect
xeroderma
pigmentosum
patient
complement
group
xpb
gene
defect
xeroderma
pigmentosum
patient
complement
group
b
cyclin
h
rvfv
also
promot
posttransl
degrad
tfiih
subunit
protein
similarli
pkr
degrad
nss
nss
bind
stabil
presenc
hand
degrad
occur
even
presenc
leptomycin
b
nuclear
export
inhibitor
indic
degrad
occur
insid
nucleu
thu
least
two
distinct
substrat
rvfv
nssmediat
degrad
pkr
tfiih
current
evid
increas
polyubiquitin
protein
presenc
nss
also
unclear
whether
sequestr
degrad
redund
function
inhibit
host
transcript
whether
snapshot
dynam
nss
function
inhibit
host
transcript
machineri
rvfv
nss
also
affect
cell
cycl
progress
cell
usual
undergo
interphas
phase
growth
phase
dna
replic
phase
growth
phase
prepar
mitosi
mitosi
chromosom
segreg
driven
centromer
bind
mitot
spindl
rvfv
nss
filament
physic
exclud
chromatin
dna
interact
sequenc
pericentromer
region
flank
centromer
sequenc
centromer
cell
infect
rvfv
exhibit
nuclear
abnorm
reduc
rate
mitosi
like
result
chromosom
cohes
segreg
defect
rvfv
nss
also
activ
classic
dna
damag
signal
pathway
via
atm
phosphoryl
ser
thr
ser
induc
cell
cycl
arrest
phase
strain
phase
strain
anoth
studi
also
show
rvfv
nss
induc
phosphoryl
ser
cell
infect
rvfv
lack
reduct
could
result
reduc
viral
replic
subsequ
decreas
cell
death
subsequ
genomewid
identif
cellular
dna
bound
rvfv
nss
perform
chromatin
immunoprecipit
ip
combin
promot
array
chip
among
nssinteract
gene
express
ten
gene
hpi
significantli
downregul
rvfvinfect
cell
gene
involv
protein
phosphoryl
ubiquitin
immun
respons
apoptosi
transcript
countermeasur
develop
rift
valley
fever
major
virul
factor
nss
review
futur
scienc
group
wwwfuturemedicinecom
develop
addit
upregul
fx
fii
fviii
tfpi
downregul
fiii
coagul
factor
occur
cell
infect
rvfv
indic
potenti
involv
nss
coagul
disord
hemorrhag
fever
result
also
indic
rvfv
nss
select
inhibit
host
gene
rvfv
accumul
lower
level
nss
protein
cell
deriv
aed
albopictu
cell
deriv
lutzomyia
longipalpi
sandfli
mammalian
cell
recent
studi
show
cell
aed
aegypti
bare
allow
express
nss
filament
format
cell
aed
aegypti
allow
nss
filament
format
earli
stage
infect
hpi
wherea
cell
albopictu
express
nss
filament
longer
period
mosquito
cell
infect
rvfv
rnai
silenc
pathway
potenti
inhibit
replic
rvfv
name
rna
secondari
structur
viral
replic
intermedi
becom
templat
form
small
virusderiv
rna
duplex
virna
allow
sequencespecif
degrad
target
mrna
via
risc
virna
specif
mostli
antiviralsens
viral
antiviralsens
l
viral
antiviralsens
appear
nt
size
signatur
piwiinteract
rna
pirna
uridin
adenosin
posit
clearli
visibl
larg
virna
nt
size
although
cell
known
defici
presenc
virna
pirna
signatur
indic
also
antivir
mechan
cell
attenu
express
nss
gene
mosquito
may
contribut
persist
infect
rvfv
first
rvfv
strain
lack
nss
clone
isol
rvfv
strain
central
african
republ
nss
encod
infram
truncat
result
abolish
known
nss
function
clone
strain
extens
use
control
viru
evalu
function
nss
clone
complet
attenu
mice
safeti
efficaci
demonstr
sheep
cattl
due
lack
function
nss
infect
anim
mount
innat
immun
respons
includ
viremia
detect
immunocompet
anim
hand
clone
caus
lethal
diseas
ifnar
mice
pkr
knockout
mice
indic
limit
factor
compet
host
innat
immun
system
reassort
clone
ssegment
reassort
consist
clone
l
result
virul
rvfv
strain
hand
reassort
consist
clone
l
complet
attenu
reassort
viru
encod
clone
ssegment
mand
lsegment
also
develop
strain
might
decreas
risk
potenti
creation
virul
reassort
rvfv
recent
develop
revers
genet
rvfv
allow
creation
recombin
rvfv
lack
nss
recombin
strain
lack
nss
nsm
test
pregnant
ewe
demonstr
efficaci
safe
veterinari
vaccin
use
vaccin
caus
detect
viremia
induc
abort
fetal
malform
pregnant
ewe
protect
ewe
wildtyp
rvfv
challeng
nsm
truncat
partli
attenu
msegment
thu
risk
revers
virul
upon
reassort
wildtyp
rvfv
may
reduc
compar
singl
delet
nss
gene
anoth
studi
also
indic
rvfv
lack
nsm
lack
nss
less
effici
mosquito
transmiss
thu
may
advantag
use
field
due
demonstr
safeti
exclud
select
agent
rule
handl
biosafeti
level
bsl
usa
upon
approv
institut
biosafeti
committe
absenc
antinss
antibodi
vaccin
anim
use
diva
although
anim
natur
infect
rvfv
rais
nss
suffici
hand
sensit
detect
antinsm
antibodi
rumin
sera
infect
rvfv
appear
difficult
antinss
liveattenu
vaccin
highli
attenu
anim
human
consid
condit
vaccin
veterinari
use
usa
well
potenti
vaccin
candid
human
use
also
exclud
select
agent
rule
handl
done
level
usa
review
lihoradova
ikegami
futur
scienc
group
deriv
wildtyp
rvfv
strain
encod
mutat
genom
four
ssegment
nine
msegment
ten
lsegment
attenu
larg
occur
mandor
lsegment
ssegment
attenu
mutat
still
identifi
among
importantli
nss
still
fulli
function
recombin
strain
encod
nss
virul
phenotyp
sinc
nss
major
virul
factor
rvfv
delet
nss
gene
vaccin
greatli
improv
safeti
profil
vaccin
hand
reduct
efficaci
due
lack
nss
may
also
need
consid
therefor
recombin
lack
function
nss
gener
revers
genet
system
efficaci
compar
parent
mous
model
vaccin
induc
viremia
vaccin
mice
without
detect
induct
vaccin
mice
protect
wildtyp
rvfv
challeng
day
postvaccin
hand
fail
develop
detect
viremia
induc
detect
pgml
sera
day
vaccin
mice
protect
wildtyp
rvfv
challeng
mean
neutral
antibodi
titer
mice
vaccin
pfu
subcutan
one
dose
day
day
day
respect
thu
reduct
neutral
antibodi
titer
might
occur
due
lack
nss
gene
vaccin
hand
attenu
mand
lsegment
encod
diva
marker
agricultur
use
develop
vaccin
doserespons
analysi
carri
rumin
anoth
strategi
make
vaccin
capabl
diva
replac
nss
gene
function
nss
deriv
phleboviru
speci
use
approach
may
still
escap
host
innat
immun
respons
attenu
origin
phleboviru
genera
consist
approxim
name
virus
larg
divid
three
major
phylogenet
group
mosquito
sandflyborn
phleboviru
group
uukuniemi
group
sever
fever
thrombocytopenia
syndrom
viru
sftsv
heartlandbhanja
group
mosquitosandflyborn
phleboviru
consist
napl
serocomplex
eg
toscana
viru
tosv
sicilian
serocomplex
eg
sandfli
fever
sicilian
viru
sfsv
punta
toro
serocomplex
eg
punta
toro
viru
adam
strain
ptv
rvf
serocomplex
icoaraci
serocomplex
eg
icoaraci
viru
frijol
serocomplex
eg
frijol
viru
recombin
encod
nss
tosv
sfsv
ptv
phylogenet
close
rvfv
nss
gener
revers
genet
efficaci
mice
test
surprisingli
induc
viral
enceph
vaccin
mice
sinc
parent
infrequ
induc
viral
enceph
mice
high
rate
neuroinvas
might
caus
uniqu
tosv
nss
function
mice
vaccin
could
protect
wildtyp
rvfv
challeng
hand
efficaci
respect
thu
chimer
show
similar
better
efficaci
mous
model
understand
phenomenon
nss
function
tosv
sfsv
ptv
analyz
tosv
nss
induc
host
gener
transcript
suppress
inhibit
gene
promot
degrad
pkr
ptv
nss
induc
host
gener
transcript
suppress
inhibit
gene
degrad
pkr
induc
sfsv
nss
induc
neither
host
gener
transcript
suppress
pkr
degrad
inhibit
gene
note
tosv
nss
retain
similar
function
rvfv
nss
except
host
gener
transcript
suppress
infect
cell
play
role
neuroinvas
viru
cell
might
trigger
neuroinvas
bloodbrain
barrier
activ
host
gene
express
hand
sfsv
ptv
nss
appear
suitabl
vaccin
develop
tosv
nss
attenu
level
sfsv
ptv
nss
compar
rvfv
nss
evalu
virul
rvfv
background
understand
risk
revers
virul
chimer
virus
furthermor
efficaci
vaccin
candid
rumin
determin
futur
although
describ
liveattenu
vaccin
statu
type
vaccin
may
found
elsewher
upon
exposur
wildtyp
rvfv
either
effect
antivir
postexposur
vaccin
might
requir
improv
prognosi
rvf
ribavirin
found
effect
rvf
alon
combin
polyllysin
carboxymethylcellulos
poli
iclc
without
liposomeencapsul
form
mice
rhesu
monkey
usa
ribavirin
approv
treatment
hepat
c
oral
ribavirin
respiratori
syncyti
viru
ribavirin
aerosol
form
wherea
advers
effect
hemolyt
anemia
teratogen
hamper
develop
ribavirin
intraven
use
treat
mani
viral
diseas
current
approv
therapeut
rvfv
infect
rvfv
evalu
potenti
postexposur
vaccin
candid
mous
model
mice
expos
wildtyp
rvfv
subcutan
administr
pfu
significantli
attenu
replic
wildtyp
rvfv
liver
spleen
improv
surviv
mice
although
administr
carri
within
min
postexposur
lack
nss
import
protect
postexposur
vaccin
regimen
may
improv
stimul
host
innat
immun
respons
hand
coexpress
nonfunct
nss
rvfvinfect
cell
might
inhibit
function
intact
nss
test
cell
infect
function
nss
gene
encod
separ
transfect
differ
vitrosynthes
rna
encod
partial
truncat
nss
lack
known
nss
function
although
truncat
nss
could
coexpress
abundantli
intact
nss
could
still
inhibit
host
gene
promot
degrad
pkr
although
nss
selfassembl
via
cterminu
form
filament
structur
figur
coexpress
truncat
nss
allow
dominantneg
suppress
nss
potenti
due
chang
nss
structur
requir
correct
protein
local
thu
approach
requir
target
nss
function
attenu
rvfv
replic
found
rvfv
nss
could
phosphoryl
uniqu
form
call
form
cell
infect
rvfv
form
complex
ikk
complex
phosphoryl
lead
degrad
nuclear
transloc
phosphoryl
nss
bind
better
nonphosphoryl
nss
curcumin
known
major
activ
compon
turmer
inhibit
convent
complex
cell
treat
curcumin
fail
arrest
cell
cycl
phase
upon
infect
reduc
rvfv
replic
indic
attenu
nss
function
curcumin
furthermor
ifnar
mice
pretreat
curcumin
sc
show
surviv
upon
infect
decreas
viru
titer
liver
thu
attenu
nss
effector
function
may
import
concept
develop
therapeut
rvf
rvfv
nss
multipl
function
allow
viru
replic
effici
shut
host
antivir
respons
liveattenu
vaccin
candid
delet
nss
highli
attenu
ssegment
lack
nss
gene
may
use
diva
rvfv
strain
encod
phleboviru
speci
exert
nss
function
partli
similar
rvfv
nss
applic
diva
furthermor
lack
nss
efficaci
postexposur
vaccin
regimen
optim
expect
final
inhibit
nss
function
effect
approach
improv
prognosi
rvfvinfect
anim
sinc
sporad
rvf
outbreak
concern
public
health
agricultur
africa
past
year
scientif
techniqu
multidisciplinari
field
greatli
advanc
best
approach
date
detect
prevent
diseas
also
chang
hand
rvfv
continu
spread
throughout
africa
even
invad
arabian
peninsula
recent
studi
indic
liveattenu
smithburn
vaccin
potenti
reassort
wildtyp
rvfv
rvf
outbreak
thu
futur
liveattenu
rvf
vaccin
reduc
environment
risk
complet
attenu
mand
lsegment
modif
viru
incap
mosquitomedi
transmiss
ssegment
larg
attenu
delet
replac
nss
gene
littl
concern
revers
virul
advantag
phlebovirus
encod
review
lihoradova
ikegami
futur
scienc
group
nss
gene
separ
n
gene
ambisens
code
strategi
hand
attenu
mand
lsegment
easi
attenu
mand
lsegment
although
attenu
mor
lsegment
complet
high
rate
abort
rumin
human
diseas
public
health
concern
effect
vaccin
therapeut
anim
human
rvf
requir
rvf
viru
rvfv
famili
bunyavirida
genu
phleboviru
negativestrand
rna
genom
mand
lsegment
rvfv
attach
dcsign
entri
via
caveolamedi
endocytosi
transcrib
viral
mrna
capsnatch
replic
viral
genom
rna
assembl
viral
genom
rna
encapsid
nucleocapsid
n
gngc
golgi
rvfv
encod
two
nonstructur
protein
nss
nsm
rvfv
lack
nss
caus
diseas
mice
cell
b
cell
play
key
role
host
immun
respons
rvfv
rvfv
nss
sequest
tfiih
promot
degrad
tfiih
pkr
rvfv
interact
chromatin
dna
induc
cell
cycl
arrest
affect
variou
host
gene
express
includ
gene
rvfv
nss
accumul
restrict
mosquito
cell
rnai
mechan
rvfv
lack
nss
eg
clone
highli
attenu
anim
may
use
differenti
infect
vaccin
anim
replac
nss
phlebovirus
decreas
efficaci
lack
nss
parent
efficaci
postexposur
vaccin
coexpress
nonfunct
nss
exhibit
dominantneg
phenotyp
curcumin
inhibit
phosphoryl
nss
may
attenu
nss
function
liveattenu
vaccin
rvf
complet
nonrevers
attenu
mand
lsegment
solv
safeti
concern
vaccin
use
environ
postexposur
vaccin
regimen
optim
rvfv
therapeut
may
develop
inhibit
nss
function
